Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel.
Biochemical markers of bone turnover have emerged as powerful tools to aid in managing osteoporosis. The newer bone markers have been intensively studied for more than a decade. As a result, we can now confidently report their clinical utility in assessing risk of rapid bone loss and fracture, and monitoring therapy in postmenopausal women with or at risk of osteoporosis. In this review, we will provide a comprehensive foundation for this utility. While there are still questions remaining to be answered, bone marker technology has matured to play an essential role in patient management. We will describe, in practical terms, how bone markers can be appropriately incorporated into clinical practice today.
Miller
P D
PD
Department of Medicine, University of Colorado Health Sciences Center and Colorado Center for Bone Research, Denver, CO 80227, USA. millerccbr@aol.com
Baran
D T
DT
Bilezikian
J P
JP
Greenspan
S L
SL
Lindsay
R
R
Riggs
B L
BL
Watts
N B
NB
D000368:Aged; D015415:Biomarkers / Q000032:analysis*; D016723:Bone Remodeling; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis*
D015415:Biomarkers